The 340B Drug Pricing Program was designed to encourage health care facilities to provide care for uninsured or underinsured patients. The program works by providing facilities a significant discount on prescription drugs in exchange for their treatment of indigent patients.
But whom does 340B really benefit? Has it fulfilled its original intent? And how do health care providers view the program’s impact?
